Search alternatives:
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
500 mg » 100 mg (Expand Search), 50 mg (Expand Search), 200 mg (Expand Search)
mg decrease » nn decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decreased (Expand Search), _ decreases (Expand Search)
500 mg » 100 mg (Expand Search), 50 mg (Expand Search), 200 mg (Expand Search)
-
1
FTY720 treatment decreased tumor growth in a xenograft model of hepatoblastoma.
Published 2019“…When tumors reached an average of 150 mm<sup>3</sup>, mice were randomized to receive vehicle (ORA-Plus, 50 μL, n = 7) or FTY720 (10 mg/kg body weight/day in ORA-Plus, 50 μL, n = 7) by oral gavage for 16 days. …”
-
2
-
3
Capzb2 coimmunoprecipitates with βIII-tubulin in brain lysates and decreases tubulin polymerization in vitro.
Published 2009“…(E) Capzb2 decreases the rate and the extent of tubulin polymerization in a concentration-dependent manner. …”
-
4
Relationship between Differential Hepatic microRNA Expression and Decreased Hepatic Cytochrome P450 3A Activity in Cirrhosis
Published 2013“…Analyses were conducted to identify miRNAs which were differentially expressed between two groups but also were significantly associated with lower hepatic CYP3A activity.</p> <p>Results</p><p>Hepatic CYP3A activity in cirrhotic livers was 1.7-fold lower than in the normal livers (0.28 ± 0.06 vs. 0.47 ± 0.07mL* min<sup>-1</sup>*mg protein<sup>-1</sup> (mean ± SEM), P=0.02). …”
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Effects of Low Dose Metformin on Metabolic Traits in Clozapine-Treated Schizophrenia Patients: An Exploratory Twelve-Week Randomized, Double-Blind, Placebo-Controlled Study
Published 2016“…Moreover, patients in the metformin at 500 mg/d and 1000 mg/d groups had a significant decrease in body mass index (BMI) after 12 weeks, with the mean decrease being 0.70 and 0.50 kg/m<sup>2</sup>, respectively. …”
-
14
B12A-05: A review and synthesis of nitrogen inputs, outputs and dynamics to support the implementation of nitrogen cap reduction in the Lake Rotorua catchment.
Published 2022“…<p>American Geophysical Union Fall Meeting Washington DC 10-14 December 2018 2018</p> <p><a href="https://agu.confex.com/agu/fm18/meetingapp.cgi/Paper/453327" target="_blank">https://agu.confex.com/agu/fm18/meetingapp.cgi/Paper/453327</a></p> <p>Nitrogen (N) budgets and dynamics in Rotorua, a 80 km2 lake with a 500 km2 catchment, have been the subject of intensive research for 50 years, and have also been the focus of large-scale restoration interventions involving both policy and management. …”
-
15
DataSheet_1_Intensive Hemodiafiltration Successfully Removes Ganciclovir Overdose and Largely Exceeds Reported Elimination During Hemodialysis—A Case Report and Review of the Liter...
Published 2020“…<p>We present the case of a kidney transplant patient (Cockroft-Gault estimated creatinine clearance 14 ml/min) who was inadvertently eight-fold overdosed with a single dose of 500 mg intravenous ganciclovir. …”
-
16
Additional file 2 of Single-cell profiling reveals periosteal signatures of impaired periosteal cells proliferation in a drill-hole model of type 2 diabetes
Published 2025“…Effect of FGL2 on Osteoblast Proliferation Under Normal and High Glucose Conditions. A. Osteoblasts were treated with vehicle or varying concentrations of FGL2 (50, 200 ng/mL) under normal (vehicle) and high glucose (4.5 mg/mL) conditions, and relative cell proliferation was assessed after 48 h to compare the effects under these different conditions. …”
-
17
TCE treatment inhibits cell proliferation and induces process outgrowth.
Published 2013“…Graph showing IC<sub>50</sub> for U87MG, HeLa and C6 cells at 200 μg/ml and for PC3 cells at 500 μg/ml. …”
-
18
-
19
Supplementary Material for: Nintedanib in IPF: Post hoc Analysis of the Italian FIBRONET Observational Study
Published 2022“…The proportion of patients with cough decreased from 50.0% to 21.2% over 12 months. Two patients experienced exacerbations, 2 patients discontinued treatment, and 27 (51.9%) reported AEs. …”
-
20
Supplementary Material for: Clinical Trial of Vadadustat in Patients with Anemia Secondary to Stage 3 or 4 Chronic Kidney Disease
Published 2017“…All subjects received low-dose supplemental oral iron (50 mg daily). The primary endpoint was the mean absolute change in hemoglobin (Hb) from baseline to the end of treatment. …”